49th Annual Psychopharmacology Conference

49th Annual Psychopharmacology Conference is organized by MGH Institute of Health Professions, Massachusetts General Hospital (MGH) Psychiatry Academy and will be held from Oct 16 - 19, 2025 at The Westin Copley Place, Boston, Massachusetts, United States of America.

Description:
This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics include ADHD, anxiety, bipolar disorder, depression, OCD, psychosis, PTSD, substance use disorders, and much more.
In every session, our faculty share data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, natural medications, combining pharmacologic and psychosocial treatments, and much more.
Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.

Learning Objectives:
By the end of this program, participants will be able to:

• Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression
• Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders
• Review the course and treatment of psychiatric disorders during pregnancy and menopause
• Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders
• Apply newer strategies in treatment of chemical abuse/dependence
• Analyze evidence-based treatment for psychiatric illness
• Assess the most recent state of the art treatment alternatives
• Assess new therapies and what is on the horizon
• Analyze the use of CBT based techniques